Global Health Clinics Ltd.

As of April 30, 2026, Global Health Clinics Ltd. carries a market capitalization of 422,646.21, placing it among publicly traded companies globally. Its enterprise value stands at 3.47M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of April 30, 2026, Global Health Clinics Ltd. has 1.04M shares outstanding.

These figures are as of April 30, 2026. The price-to-sales ratio is 32.33, and the price-to-book ratio stands at -0.08.

These figures are as of April 30, 2026. The EV/Sales ratio of 265.25 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 3.47M versus a market cap of 422,646.21, with the gap driven by net debt and cash on the balance sheet.

As of April 30, 2026, Global Health Clinics Ltd. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -53.83, indicating conservative leverage, while an interest coverage ratio of -3.77 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended April 30, 2026. Return on assets (ROA) is negative at -4,419.94, reflecting losses generated across the asset base.

As of the close on October 9, 2026, Global Health Clinics Ltd.'s stock has gained approximately 344.44% over the past 52 weeks. The 50-day moving average sits at 0.40, while the 200-day moving average is 18.49.

Over the twelve months ended April 30, 2026, Global Health Clinics Ltd. generated 13,073.00 in revenue and converted that into -1.36M in net income, yielding earnings per share of -1.30. EBITDA reached -1.07M, while operating income came in at -1.07M.

As of April 30, 2026, Global Health Clinics Ltd. holds 31,936.00 in cash and equivalents against 2.98M in total debt, resulting in a net debt position of 2.95M. Total book value stands at -5.63M, with working capital of -5.53M providing operational flexibility.

Global Health Clinics Ltd. produced -574,128.00 in operating cash flow over the twelve months ended April 30, 2026.

Over the twelve months ended April 30, 2026, Global Health Clinics Ltd. posted a gross margin of 67.99, reflecting its pricing power and cost economics. The operating margin of -8,220.20 and net profit margin of -10,385.67 provide insight into operational efficiency.

These figures cover the twelve months ended April 30, 2026. Free cash flow yield is negative at -135.84: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -142.25, meaning Global Health Clinics Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Global Health Clinics Ltd.'s most recent stock split took place on August 17, 2026 with a 9:1 split ratio.

As of April 30, 2026, Global Health Clinics Ltd. has an Altman Z-Score of -1,450.37, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.